Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/125366
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRosa Rosa, Juan Manuel-
dc.contributor.authorLeskela, Susanna-
dc.contributor.authorCristóbal Lana, Eva-
dc.contributor.authorSantón, Almudena-
dc.contributor.authorLópez García, Ma. Ángeles-
dc.contributor.authorMuñoz, Gloria-
dc.contributor.authorPérez Mies, Belén-
dc.contributor.authorBiscuola, Michele-
dc.contributor.authorPrat, Jaime-
dc.contributor.authorOliva, Esther-
dc.contributor.authorSoslow, Robert A.-
dc.contributor.authorMatias-Guiu, Xavier-
dc.contributor.authorPalacios, José-
dc.date.accessioned2018-10-16T13:24:26Z-
dc.date.available2018-10-16T13:24:26Z-
dc.date.issued2016-11-01-
dc.identifier.urihttps://hdl.handle.net/2445/125366-
dc.description.abstractUndifferentiated and dedifferentiated endometrial carcinomas are rare and highly aggressive subtypes of uterine cancer, not well characterized at a molecular level. To investigate whether dedifferentiated carcinomas carry molecular genetic alterations similar to those of pure undifferentiated carcinomas, and to gain insight into the pathogenesis of these tumors, we selected a cohort of 18 undifferentiated endometrial carcinomas, 8 of them with a well-differentiated endometrioid carcinoma component (dedifferentiated endometrioid carcinomas), and studied them by immunohistochemistry and massive parallel and Sanger sequencing. Whole-exome sequencing of the endometrioid and undifferentiated components, as well as normal myometrium, was also carried out in one case. According to The Cancer Genome Atlas classification, we distributed 95% of the undifferentiated carcinomas in this series as follows: (a) hypermutated tumors with loss of any mismatch repair protein expression and microsatellite instability (eight cases, 45%); (b) ultramutated carcinomas carrying mutations in the exonuclease domain of POLE (two cases, 11%); (c) high copy number alterations (copy-number high) tumors group exhibiting only TP53 mutations and high number of alterations detected by FISH (two cases, 11%); and (d) low copy number alterations (copy-number low) tumors with molecular alterations typical of endometrioid endometrial carcinomas (five cases, 28%). Two of the latter cases, however, also had TP53 mutations and higher number of alterations detected by FISH and could have progressed to a copy-number high phenotype. Most dedifferentiated carcinomas belonged to the hypermutated group, whereas pure undifferentiated carcinomas shared molecular genetic alterations with copy-number low or copy-number high tumors. These results indicate that undifferentiated and dedifferentiated endometrial carcinomas are molecularly heterogeneous tumors, which may have prognostic value.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1038/modpathol.2016.132-
dc.relation.ispartofModern Pathology, 2016, vol. 29, num. 11, p. 1390-1398-
dc.relation.urihttps://doi.org/b10.1038/modpathol.2016.132-
dc.rights(c) Springer Nature, 2016-
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationCàncer d'endometri-
dc.subject.classificationGenètica molecular-
dc.subject.otherEndometrial cancer-
dc.subject.otherMolecular genetics-
dc.titleMolecular genetic heterogeneity in undifferentiated endometrial carcinomas-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.date.updated2018-07-24T12:16:02Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid27491810-
dc.identifier.pmid27895324-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Rosa-RosaJM.pdf963.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.